$PHAS PhaseBio Pharmaceuticals Inc Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in PhaseBio Pharmaceuticals Inc.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in PhaseBio Pharmaceuticals Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in PhaseBio Pharmaceuticals Inc for free.

CIK Number: 0001169245
IRS Number: 030375697
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: PHAS
Company Address: 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN 19355
Phone number: (610) 981-6500
Former name: DT BIOSCIENCES INC, date of change: 2002-03-15
Former name: Phase Biosciences Inc, date of change: 2006-10-13

PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapies for cardiopulmonary diseases. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.

PhaseBio Pharmaceuticals Inc Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 09 2021PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...Option ExerciseA4.31234,0001,008,540234,000
Feb 09 2021PHASPhaseBio Pharmaceu ...Hanson KristopherVP, Head of LegalOption ExerciseA4.3136,000155,16036,000
Feb 09 2021PHASPhaseBio Pharmaceu ...Hanson KristopherVP, Head of LegalOption ExerciseA4.3136,000155,16036,000
Feb 09 2021PHASPhaseBio Pharmaceu ...York MichaelVP, Corporate Devel ...Option ExerciseA4.3136,000155,16036,000
Feb 09 2021PHASPhaseBio Pharmaceu ...York MichaelVP, Corporate Devel ...Option ExerciseA4.3136,000155,16036,000
Feb 09 2021PHASPhaseBio Pharmaceu ...Arnold Susan ElizabethVP, Preclinical and ...Option ExerciseA4.3136,000155,16036,000
Feb 09 2021PHASPhaseBio Pharmaceu ...Arnold Susan ElizabethVP, Preclinical and ...Option ExerciseA4.3136,000155,16036,000
Feb 09 2021PHASPhaseBio Pharmaceu ...Sharp John PChief Financial Off ...Option ExerciseA4.3176,500329,71576,500
Feb 09 2021PHASPhaseBio Pharmaceu ...Sharp John PChief Financial Off ...Option ExerciseA4.3176,500329,71576,500
Feb 09 2021PHASPhaseBio Pharmaceu ...Lee John SangChief Medical Offic ...Option ExerciseA4.3176,500329,71576,500
Feb 09 2021PHASPhaseBio Pharmaceu ...Lee John SangChief Medical Offic ...Option ExerciseA4.3176,500329,71576,500
Feb 09 2021PHASPhaseBio Pharmaceu ...Burkhardt GlenVP, Human ResourcesOption ExerciseA4.3136,000155,16036,000
Feb 09 2021PHASPhaseBio Pharmaceu ...Burkhardt GlenVP, Human ResourcesOption ExerciseA4.3136,000155,16036,000
Dec 04 2020PHASPhaseBio Pharmaceu ...HARRIGAN EDMUNDDirectorBuyP4.126,00024,7206,0000 to 6 K
Nov 23 2020PHASPhaseBio Pharmaceu ...Sharp John PChief Financial Off ...GrantA3.001,3053,91541,30540 K to 41.3 K (+3.26 %)

View all PhaseBio Pharmaceuticals Inc insider transactions.